'Game changer' antibiotic and others in works for superbug.
- Published in:
- Nature Medicine, 2011, v. 17, n. 1, p. 10, doi. 10.1038/nm0111-10
- By:
- Publication type:
- Article
Works matching DE "SANOFI Pasteur SA"
Results: 7
1
2
1 September News.
- Published in:
- Clinical Infectious Diseases, 2013, v. 57, n. 5, p. i, doi. 10.1093/cid/cit457
- Publication type:
- Article
3
News.
- Published in:
- Clinical Infectious Diseases, 2011, v. 52, n. 3, p. i, doi. 10.1093/cid/ciq173
- Publication type:
- Article
4
Licensure of a High-Dose Inactivated Inluenza Vaccine for Persons Aged ≥65 Years (Fluzone High-Dose) and Guidance for Use -- United States, 2010.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2010, v. 59, n. 16, p. 485
- Publication type:
- Article
5
Race Is On for Effective Dengue Vaccine.
- Published in:
- JAMA: Journal of the American Medical Association, 2010, v. 304, n. 13, p. 1430, doi. 10.1001/jama.2010.1386
- By:
- Publication type:
- Article
6
FDA actions.
- Published in:
- OB/GYN Clinical Alert, 2011, p. 2
- Publication type:
- Article
7
Sanofi's dengue vaccine first to complete phase 3.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 7, p. 605, doi. 10.1038/nbt0714-605a
- By:
- Publication type:
- Article